Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000306898 is annotated as a novel transcript, antisense to KIAA1210, indicating it is an RNA molecule proceeding from the DNA strand opposite to the KIAA1210 gene locus. Antisense transcripts often have regulatory functions in gene expression, such as modulating the expression of the corresponding sense gene through RNA interference or epigenetic modification, but there is no published functional information or evidence identifying this transcript as a biologically or therapeutically relevant target. KIAA1210 itself is a protein-coding gene with expression in testis and involvement in spermatogenesis, but this specific antisense transcript remains uncharacterized with unknown function or role in disease. No drugs, biomarkers, or safety data are associated. If you seek information on KIAA1210 (rather than the antisense transcript), more detailed functional and molecular data are available[1]. Otherwise, ENSG00000306898, as currently represented, is not recognized as a therapeutic or drug discovery target and likely reflects incomplete annotation or a non-coding regulatory RNA species.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel transcript, antisense to KIAA1210.